TG THERAPEUTICS, INC. (TGTX) FY2026 Q2 Balance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
TG THERAPEUTICS, INC. (TGTX) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$268.49 MLiabilities$1.04 BCurrent assets$1.15 BNon-current liabilities$767.05 MAssets$1.64 BEquity$604.08 MGross equity(calculated)$1.86 BNon-current assets$493.94 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, netInventoryShort-term investment securitiesOther current assetsDeferred tax assetsNon-current inventoriesLong-term investment securitiesRight of use assetsOther noncurrent assetsRestricted cashAccounts payable and accrued expensesAccrued compensationDeferred revenue - current portionLease liability – current portionOther current liabilitiesLoan payable – non-currentDeferred revenue, non-current portionLease liability – non-currentAdditional paid-in capitalCommon stock, $0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 159,949,330 and 158,849,596 shares issued, 153,077,784 and 155,305,953 shares outstanding at June 30, 2026 and December 31, 2025, respectively)Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitTreasury stock, at cost, 6,871,546 and 3,543,643 shares at June 30, 2026 and December 31, 2025, respectivelyAccounts payable and accrued expensesAccounts payable and accrued expenses$213.69 MCurrent liabilitiesCurrent liabilities$268.49 MAccrued compensationAccrued compensation$35.21 MDeferred revenue - current portionDeferred revenue - current portion$16.83 MLiabilitiesLiabilities$1.04 BCurrent assetsCurrent assets$1.15 BLease liability – current portionLease liability – current portion$1.91 MCash and cash equivalentsCash and cash equivalents$482.58 MOther current liabilitiesOther current liabilities$857.00 KNon-current liabilitiesNon-current liabilities$767.05 MAssetsAssets$1.64 BAccounts receivable, netAccounts receivable, net$401.57 MLoan payable – non-currentLoan payable – non-current$745.39 MInventoryInventory$147.97 MShort-term investment securitiesShort-term investment securities$69.67 MEquityEquity$604.08 MDeferred revenue, non-current portionDeferred revenue, non-current portion$14.53 MOther current assetsOther current assets$43.90 MLease liability – non-currentLease liability – non-current$7.14 MGross equity (calculated)Gross equity(calculated)$1.86 BDeferred tax assetsDeferred tax assets$343.43 MNon-current assetsNon-current assets$493.94 MNon-current inventoriesNon-current inventories$75.49 MLong-term investment securitiesLong-term investment securities$64.37 MRight of use assetsRight of use assets$7.09 MAdditional paid-in capitalAdditional paid-in capital$1.86 BOther noncurrent assetsOther noncurrent assets$2.21 MRestricted cashRestricted cash$1.36 MCommon stock, $0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 159,949,330 and 158,849,596 shares issued, 153,077,784 and 155,305,953 shares outstanding at June 30, 2026 and December 31, 2025, respectively)Common stock$160.00 KAccumulated deficitAccumulated deficit−$1.05 BTreasury stock, at cost, 6,871,546 and 3,543,643 shares at June 30, 2026 and December 31, 2025, respectivelyTreasury stock−$200.23 M
Chart details

TG THERAPEUTICS, INC. (TGTX) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
1,639,629,000 US dollars
Current assets
1,145,687,000 US dollars
Non-current assets
493,942,000 US dollars
Liabilities
1,035,546,000 US dollars
Current liabilities
268,493,000 US dollars
Non-current liabilities
767,053,000 US dollars
Equity
604,083,000 US dollars
Cash and cash equivalents
482,575,000 US dollars
Accounts receivable, net
401,565,000 US dollars
Inventory
147,973,000 US dollars
Short-term investment securities
69,673,000 US dollars
Other current assets
43,901,000 US dollars
Deferred tax assets
343,428,000 US dollars
Non-current inventories
75,486,000 US dollars
Long-term investment securities
64,368,000 US dollars
Right of use assets
7,085,000 US dollars
Other noncurrent assets
2,211,000 US dollars
Restricted cash
1,364,000 US dollars
Accounts payable and accrued expenses
213,693,000 US dollars
Accrued compensation
35,205,000 US dollars
Deferred revenue - current portion
16,825,000 US dollars
Lease liability – current portion
1,913,000 US dollars
Other current liabilities
857,000 US dollars
Loan payable – non-current
745,387,000 US dollars
Deferred revenue, non-current portion
14,525,000 US dollars
Lease liability – non-current
7,141,000 US dollars
Additional paid-in capital
1,858,606,000 US dollars
Common stock, $0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 159,949,330 and 158,849,596 shares issued, 153,077,784 and 155,305,953 shares outstanding at June 30, 2026 and December 31, 2025, respectively)
160,000 US dollars
Accumulated deficit
negative 1,054,457,000 US dollars
Treasury stock, at cost, 6,871,546 and 3,543,643 shares at June 30, 2026 and December 31, 2025, respectively
negative 200,226,000 US dollars
Gross equity (calculated)
1,858,766,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
TG THERAPEUTICS, INC. (TGTX) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!